RiverVest Venture Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.14M | Hold |
1,441,444
| – | – | 16.6% | 3 |
|
|
2024
Q2 | $1.37M | Hold |
1,441,444
| – | – | 20.01% | 3 |
|
|
2024
Q1 | $1.56M | Hold |
1,441,444
| – | – | 19.12% | 3 |
|
|
2023
Q4 | $793K | Hold |
1,441,444
| – | – | 2.92% | 4 |
|
|
2023
Q3 | $3.04M | Hold |
1,441,444
| – | – | 7.52% | 4 |
|
|
2023
Q2 | $3.78M | Hold |
1,441,444
| – | – | 4.19% | 5 |
|
|
2023
Q1 | $4.57M | Hold |
1,441,444
| – | – | 5.29% | 5 |
|
|
2022
Q4 | $3.88M | Hold |
1,441,444
| – | – | 4.52% | 4 |
|
|
2022
Q3 | $4.2M | Hold |
1,441,444
| – | – | 4.87% | 4 |
|
|
2022
Q2 | $4.21M | Hold |
1,441,444
| – | – | 6.19% | 4 |
|
|
2022
Q1 | $10.2M | Hold |
1,441,444
| – | – | 10.46% | 3 |
|
|
2021
Q4 | $23.1M | Buy |
+1,441,444
| New | +$23.1M | 16.45% | 3 |
|